Pathogenesis of Psoriasis vulgaris and Current Management and Therapeutic Strategies Including the Role of Emollients—A Review of the Current Literature
Source abstract
Abstract
Psoriasis is a chronic inflammatory skin disease with a complex clinical picture that remains incurable and requires ongoing dermatological care. The purpose of this literature review is to identify the latest therapeutic strategies used to treat psoriasis, taking into account both the efficacy of modern approaches and their impact on patients’ quality of life. The cornerstone of psoriasis treatment remains regular skin care through the use of emollients, which support the effectiveness of other topical therapies used such as corticosteroids. In addition, the review presents current epidemiological data on the prevalence of psoriasis worldwide, with a focus on European countries and Poland. The article discusses innovative approaches in therapy, including targeted biologics, modern forms of topical therapy, and the role of emollients in comprehensive skin care, as well as various cosmetological treatments aimed at removing the excessively accumulated stratum corneum, and improving the degree of hydration of psoriatic skin. The review also included current expert recommendations and guidelines from scientific societies that guide the treatment and care of psoriatic skin. The results of the analyses underscore the need for targeted therapies and the importance of a holistic approach to patient care. As the collected data indicate, the possibilities for effective topical and systemic treatment of psoriasis are increasing all the time due to research into newer and newer active substances that are expected to improve the efficacy of treatment, the comfort of life for psoriasis patients and reduce the side effects of long-term therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Psoriasis: Treatment and Pathogenesis · Phytochemistry and biological activity of medicinal plants · Phytochemistry Medicinal Plant Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Applied Chemistry, Casimir Pulaski Radom University, Street Chrobrego 27, 26-600 Radom, Poland
Department of Health Sciences and Physical Culture, Casimir Pulaski Radom University, Street Chrobrego 27, 26-600 Radom, Poland
References (100+)
Show source-provided references
1. Preparaty pochodzenia roślinnego w pielęgnacji skóry u chorych z łuszczycą
2. Importance of Basic Therapy in Psoriasis10.1111/ddg.12615 ↗
3. Treatment of Chronic Plaque Psoriasis: An Overview on Current Update
4. Man, A.-M., Orăsan, M.S., Hoteiuc, O.-A., Olănescu-Vaida-Voevod, M.-C., and Mocan, T. (2023). Inflammation and Psoriasis: A Comprehensive Review. Int. J. Mol. Sci., 24.10.3390/ijms242216095 ↗
5. Psoriasis10.1016/S0140-6736(20)32549-6 ↗
6. Global Psoriasis Atlas. National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study10.1136/bmj.m1590 ↗
7. Dascălu, R.C., Bărbulescu, A.L., Stoica, L.E., Dinescu, Ș.C., Biță, C.E., Popoviciu, H.V., Ionescu, R.A., and Vreju, F.A. (2024). A Contemporary, Multifaced Insight into Psoriasis Pathogenesis. J. Pers. Med., 14.10.3390/jpm14050535 ↗
8. Psoriasis Therapies in 2024 and Beyond
9. From Pathogenesis to Current Treatment of the Cutaneous Psoriasis—A Literature Review10.12775/JEHS.2023.49.01.004 ↗
10. Systemic steroids in the treatment of psoriasis: What is fact, what is fiction?10.1111/j.1468-3083.2012.04656.x ↗
11. Advances in psoriasis research: From pathogenesis to therapeutics10.1016/j.lfs.2024.122991 ↗
12. A New Prescription Emollient Device (PED) for Psoriasis of Sensitive Areas and Folds: A Randomized Prospective Open Trial
13. Łuszczyca—Pielęgnacja i postępowanie w gabinecie kosmetycznym
14. Efficacy and tolerability of Cerkobaza and Cerkoderm 15 emollients in combination with narrow band UVB phototherapy in psoriatic patients
15. Adebajo, A., Boehncke, W.H., Gladman, D., and Mease, P. (2016). Psoriasis. Psoriatic Arthritis and Psoriasis, Springer.10.1007/978-3-319-19530-8 ↗
16. Scaly signs in dermatology10.4103/0378-6323.25653 ↗
17. Rendon, A., and Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.10.3390/ijms20061475 ↗
18. Farmakoterapia łuszczycy
19. Farmakologiczne i niefarmakologiczne metody terapii łuszczycy ze szczególnym uwzględnieniem leków biologicznych
20. Metody leczenia łuszczycy w oparciu o informacje uzyskane od pacjentów dotkniętych tą chorobą
21. Leczenie łuszczycy zwyczajnej—Rekomendacje ekspertów Polskiego Towarzystwa Dermatologicznego. Część I: Łuszczyca łagodna, łuszczyca wieku dziecięcego
22. W jaki sposób miarodajnie oceniać nasilenie łuszczycy?
23. Łuszczyca. rekomendacje diagnostyczno-terapeutyczne Polskiego towarzystwa Dermatologicznego. część I: Łuszczyca łagodna
24. Current Severe Psoriasis and the Rule of Tens10.1111/j.1365-2133.2005.06502.x ↗
25. Keratolytics and Emollients and Their Role of Psoriasis a Systematic Review10.1007/s13555-015-0068-3 ↗
26. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis
27. Li, H.J., and Kim, M. (2023). Challenges and Future Trends in the Treatment of Psoriasis. Int. J. Mol. Sci., 24.10.3390/ijms241713313 ↗
28. Wspólne wytyczne AAD–NPF dotyczące opieki nad pacjentem i leczeniem łuszczycy za pomocą terapii miejscowej i alternatywnych metod leczenia w celu zmniejszenia nasilenia objawów łuszczycy10.1016/j.jaad.2020.07.087 ↗
29. Baran, A., and Flisiak, I. (2025, June 15). Jaka Jest Klasyfikacja Miejscowych Glikokortykosteroidów ze Względu na Siłę Działania i Jakie Jest Znaczenie Praktyczne Podziału? Medycyna Praktyczna. Available online: https://www.mp.pl/pytania/pediatria/chapter/B25.QA.7.1.40.
30. Zastosowanie fototerapii w leczeniu łuszczycy zwyczajnej
31. Przegląd metod fototerapii w leczeniu łuszczycy
32. Wspólne wytyczne Amerykańskiej Akademii Dermatologii i Narodowej Fundacji Łuszczycy dotyczące opieki nad leczeniem łuszczycy za pomocą fototerapii10.1016/j.jaad.2019.04.042 ↗
33. Wspólne wytyczne AAD-NPF dotyczące postępowania i leczenia łuszczycy lekami biologicznymi10.1016/j.jaad.2018.11.057 ↗
34. Wspólne wytyczne Amerykańskiej Akademii Dermatologii i Narodowej Fundacji Łuszczycy dotyczące leczenia łuszczycy za pomocą ogólnoustrojowych terapii niebiologicznych10.1016/j.jaad.2020.02.044 ↗
35. Tapinarof w leczeniu łuszczycy
36. Konarska, I. (2025, June 15). FDA Zatwierdziła Miejscowy Tapinarof w Leczeniu Łuszczycy Plackowatej. Medscape. Available online: https://www.termedia.pl/dermatologia/FDA-zatwierdzila-miejscowy-tapinarof-w-leczeniu-luszczycy-plackowatej,47231.html.
37. Use of biological therapies for the management of pustular psoriasis: A new era?10.2147/CCID.S407812 ↗
38. Łuszczyca cz. 1—Obraz kliniczny, patogeneza, leczenie systemowe10.32383/farmpol/168683 ↗
39. Skuteczność i bezpieczeństwo bimekizumabu u pacjentów z umiarkowaną do ciężkiej łuszczycą plackowatą: Dwuletnie wyniki pośrednie otwartego rozszerzenia randomizowanego badania fazy 3b BE RADIANT10.1016/j.jaad.2023.04.063 ↗
40. Promising New Treatments for Psoriasis10.1155/2013/980419 ↗
41. (2025, June 15). Bimekizumab—Medicine Overview; European Medicines Agency: Amsterdam, The Netherlands. Available online: https://www.ema.europa.eu/en/medicines/human/EPAR/bimzelx.
42. Adams, R., MarooF, A., Baker, T., DG Lawson, A., Oliver, R., Paveley, R., Rapecki, S., Shaw, S., Vajjah, P., and Zachód, S. (2020). Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F. Front. Immunol., 11.10.3389/fimmu.2020.01894 ↗
43. Lesiak, A., and Ciążyńska, M. (2020). Risankizumab Jako Skuteczna i Długodziałająca Opcja Terapeutyczna w Leczeniu Łuszczycy, Forum Media Polska. Available online: https://www.wiadomoscidermatologiczne.pl/artykul/risankizumab-jako-skuteczna-i-dlugodzialajaca-opcja-terapeutyczna-w-leczeniu-luszczycy.
44. Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study10.2147/CCID.S402183 ↗
45. Emollients in dermatological treatment: Position paper of the experts’ group
46. Mijaljica, D., Spada, F., and Harrison, I.P. (2022). Topical moisturisers for the management of psoriasis vulgaris. Psoriasis-New Research, IntechOpen.10.5772/intechopen.101964 ↗
47. Almeida, C., Madeira, A., Marto, J., Graça, A., Pinto, P., and Ribeiro, H. (2019). Monfortinho Thermal Water-Based Creams: Effects on Skin Hydration, Psoriasis, and Eczema in Adults. Cosmetics, 6.10.3390/cosmetics6030056 ↗
48. Topical Therapies in Psoriasis10.4103/2229-5178.209622 ↗
49. Kang, S.-Y., Um, J.-Y., Chung, B.-Y., Lee, S.-Y., Park, J.-S., Kim, J.-C., Park, C.-W., and Kim, H.-O. (2022). Moisturizer in Patients with Inflammatory Skin Diseases. Medicina, 58.10.3390/medicina58070888 ↗
50. A Clinical Investigation of the Performance and Safety of Epaderm®, an Emollient Cream10.2147/CCID.S316794 ↗
51. Maroto-Morales, D., Montero-Vilchez, T., and Arias-Santiago, S. (2021). Study of Skin Barrier Function in Psoriasis: The Impact of Emollients. Life, 11.10.3390/life11070651 ↗
52. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders10.2165/00128071-200304110-00005 ↗
53. Improvements in epidermal function prevent relapse of psoriasis: A self-controlled study10.1111/ced.13888 ↗
54. Efficacy and safety of a topical moisturizer containing linoleic acid and ceramide for mild-to-moderate psoriasis vulgaris: A multicenter randomized controlled trial10.1111/dth.14263 ↗
55. Kowalska, M.K., Orłowska, S.M., and Bednarczyk, Ł. (2024). Applied Research on Atopic Dermatitis with Special Emphasis on the Role of Emollients in This Disorder: A Review. Appl. Sci., 14.10.3390/app14188315 ↗
56. Gorski, J., Proksch, E., Baron, J.M., Schmid, D., and Zhang, L. (2020). Dexpanthenol in Wound Healing after Medical and Cosmetic Interventions (Postprocedure Wound Healing). Pharmaceuticals, 13.10.3390/ph13070138 ↗
57. Characterization of a novel standardized human three-dimensional skin wound healing model using non-sequential fractional ultrapulsed CO2 laser treatments10.1002/lsm.22341 ↗
58. Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis10.1111/jdv.16691 ↗
59. Ceramides in Skin Health and Disease: An Update10.1007/s40257-021-00619-2 ↗
60. Łuszczyca cz. 2—Leczenie miejscowe, fototerapia oraz pielęgnacja skóry
61. Topical Treatment of Psoriasis Vulgaris
62. Matwiejuk, M., Mysliwiec, H., Chabowski, A., and Flisiak, I. (2020). The Role of Sphingolipids in the Pathogenesis of Psoriasis. Metabolites, 12.10.3390/metabo12121171 ↗
63. Serum sphingolipid level in psoriatic patients with obesity10.5114/ada.2019.91422 ↗
64. The Role of a Novel Generation of Emollients, ‘Emollients Plus’, in Atopic Dermatitis10.2147/CCID.S389697 ↗
65. Topical use of dexpanthenol: A 70th anniversary article10.1080/09546634.2017.1325310 ↗
66. Managing dry skin in patients with comorbidities or with advanced age: Unmet needs and roles for products containing potential emollient-plus ingredients10.1080/09546634.2024.2326171 ↗
67. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis10.1007/s12016-018-8702-3 ↗
68. Zhang, S., Zhang, J., Yu, J., Chen, X., Zhang, F., Wei, W., Zhang, L., Chen, W., Lin, N., and Wu, Y. (2021). Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells. Front. Immunol., 12.10.3389/fimmu.2021.635076 ↗
69. Wielowieyska-Szybińska, D., and Wojas-Pelc, A. (2012). Przebieg i postępowanie w łuszczycy zwykłej. Przebieg i Postępowanie w Łuszczycy Zwykłej, Katedra i Klinika Dermatologii Collegium Medicum Uniwersytetu Jagiellońskiego.
70. Psoriasis (Chronic Plaque)
71. Double-Blind Clinical Study Reveals Synergistic Action Between Alpha-Hydroxy Acid and Betamethasone Lotions Towards Topical Treatment of Scalp Psoriasis10.1046/j.1468-3083.2000.00006.x ↗
72. n-3 Polyunsaturated Fatty Acids Supplementation in Psoriasis: A Review10.1186/s41110-016-0029-3 ↗
73. Emollients, Moisturizers and Keratolytic Agents in Psoriasis10.1016/j.clindermatol.2008.01.015 ↗
74. Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties10.1007/s13555-021-00611-y ↗
75. Pilot, Multicenter, Double-Blind, Randomized Placebo-Controlled Bilateral Comparative Study of a Combination of Calcipotriene and Nicotinamide for the Treatment of Psoriasis10.1016/j.jaad.2009.10.016 ↗
76. The Role of the Adjuvant Aesthetic Therapy in the Lives of Patients with Psoriatic Disease10.5114/ada.2022.118996 ↗
77. Pujer, K. (2020). Łuszczyca—Etiopatogeneza i Leczenie. Problemy Nauk Medycznych i Nauk o Zdrowiu, Exante Wydawnictwo Naukowe. Tom 11.
78. Ghaseminejad-Bandpey, A., Etemadmoghadam, S., and Jabbari, B. (2024). Botulinum Toxin Treatment of Psoriasis—A Comprehensive Review. Toxins, 16.10.3390/toxins16100449 ↗
79. Botulinum Toxin Injection Shows Promise in Nail Psoriasis: A Comparative Randomized Controlled Trial10.1016/j.jdin.2024.03.021 ↗
80. Le, S., Wu, X., Dou, Y., Song, T., Fu, H., Luo, H., Zhang, F., and Cao, Y. (2024). Promising strategies in natural products treatments of psoriasis-update. Front. Med., 11.10.3389/fmed.2024.1386783 ↗
81. Unconventional treatment options in psoriasis: A review10.25259/IJDVL_22_2021 ↗
82. Review of natural compounds for potential psoriasis treatment10.1007/s10787-023-01178-0 ↗
83. Evaluation of the antipsoriatic activity of Aloe vera leaf extract using a mouse tail model of psoriasis10.1002/ptr.3589 ↗
84. Gendrisch, F., Haarhaus, B., Krieger, N., Quirin, K.W., Schempp, C.M., and Wölfle, U. (2021). The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes. Biomolecules, 11.10.3390/biom11030371 ↗
85. Evaluation of the efficacy of a topical chamomile-pumpkin oleogel for the treatment of plaque psoriasis: An intra-patient, double-blind, randomized clinical trial10.15419/bmrat.v5i11.499 ↗
86. Anti-inflammatory Effects of Matricaria chamomilla Extracts on BALB/c Mice Macrophages and Lymphocytes
87. Lairikyengbam, D., Wetterauer, B., Schmiech, M., Jahraus, B., Kirchgessner, H., Wetterauer, P., Berschneider, K., Beier, V., Niesler, B., and Balta, E. (2024). Comparative analysis of whole plant, flower and root extracts of Chamomilla recutita L. and characteristic pure compounds reveals differential anti-inflammatory effects on human T cells. Front. Immunol., 15.10.3389/fimmu.2024.1388962 ↗
88. Matricaria chamomilla—Why is it worth to keep it in home first aid kit?
89. Essential Oil of Matricaria chamomilla Alleviate Psoriatic-Like Skin Inflammation by Inhibiting PI3K/Akt/mTOR and p38MAPK Signaling Pathway10.2147/CCID.S445008 ↗
90. Comparative analysis between Chamomilla recutita and corticosteroids on wound healing. An in vitro and in vivo study10.1002/ptr.2612 ↗
91. Seyedjavadi, S.S., Khani, S., Eslamifar, A., Ajdary, S., Goudarzi, M., Halabian, R., Akbari, R., Zare-Zardini, H., Imani Fooladi, A.A., and Amani, J. (2020). The Antifungal Peptide MCh-AMP1 Derived From Matricaria chamomilla Inhibits Candida albicans Growth via Inducing ROS Generation and Altering Fungal Cell Membrane Permeability. Front. Microbiol., 10.10.3389/fmicb.2019.03150 ↗
92. Chemical Composition, Antioxidant and Antimicrobial Activity of Chamomile Flowers Essential Oil (Matricaria chamomilla L.)10.1080/0972060X.2016.1224689 ↗
93. Alesci, A., Lauriano, E.R., Fumia, A., Irrera, N., Mastrantonio, E., Vaccaro, M., Gangemi, S., Santini, A., Cicero, N., and Pergolizzi, S. (2022). Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful?. Molecules, 27.10.3390/molecules27061953 ↗
94. Influence of phytochemicals in induced psoriasis (Review)
95. Aloe Barbadensis Miller (Aloe Vera)10.1024/0300-9831/a000797 ↗
96. Composition and applications of Aloe vera leaf gel10.3390/molecules13081599 ↗
97. Value-added products of Aloe species: Panacea to several maladies10.1016/j.sajb.2020.12.025 ↗
98. The Effect of Aloe Vera Clinical Trials on Prevention and Healing of Skin Wound: A Systematic Review
99. Catalano, A., Ceramella, J., Iacopetta, D., Marra, M., Conforti, F., Lupi, F.R., Gabriele, D., Borges, F., and Sinicropi, M.S. (2024). Aloe vera-An Extensive Review Focused on Recent Studies. Foods, 13.10.3390/foods13132155 ↗
100. Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo-controlled, double-blind study10.1046/j.1365-3156.1996.d01-91.x ↗